Comparative Efficacy of PD‐1 Inhibitor‐Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II–IIIa NSCLC: A Real‐World Retrospective Study

ABSTRACT Background Although neoadjuvant chemoimmunotherapy has emerged as a promising approach for resectable non‐small cell lung cancer (NSCLC), comparative real‐world data on different PD‐1 inhibitors are limited. This study compared the clinical efficacy, pathological response, survival, and saf...

Descrición completa

Detalles Bibliográficos

Principais autores:	Bo Yan, Xiaoxuan Sun, Yan Sheng, Ran Zhang, Yanjun Su, Yulong Chen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-07-01
Series:	Thoracic Cancer
Assuntos:	chemoimmunotherapy immune checkpoint inhibitors neoadjuvant therapy non‐small cell lung cancer surgery
Acceso en liña:	https://doi.org/10.1111/1759-7714.70123
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!